Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease.

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...